Panelists discuss how physician-patient conversations about newer multiple myeloma therapies have evolved to include detailed ...

ABIVAX is a French biotech with a novel ulcerative colitis treatment in phase 3 trials. Click here to find out why I am ...

DelveInsight’s, “Chronic Kidney Disease Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and ...

Aptevo Therapeutics reports strong remission rates in AML patients using mipletamig plus ven/aza, with Cohort 2 enrollment ...

Q4 2024 Earnings Call Transcript March 25, 2025 Corvus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

The label expansion could help J&J establish Tremfya as a successor to Stelara, which is now facing a growing biosimilar ...

Arialief offers a satisfaction guarantee, allowing customers to try the product risk-free. If users do not experience the ...

The following is a summary of “Tebentafusp Induces a T-Cell–Driven Rash in Melanocyte-Bearing Skin as an Adverse Event ...

Q4 2024 Earnings Call Transcript March 20, 2025 Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0 ...

A 12-week study on postmenopausal women with obesity found that those who followed a consistent walking plan experienced a ...

Several medications now calm painful inflammation in the intestines. Diets free of ultraprocessed foods also help ...